Form D · Other Technology
Sistema.bio, Inc.
Mexico City, O5 · CIK 0001903921
Offering snapshot reported Aug 6, 2024 · SEC filing
- Reported sold
- $4.25M Offering amount: $7M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 25, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2024 | Initial | $4,250,000 | No comparison | 6 | SEC filing |
| Jan 25, 2022 | Initial | $9,999,973 | No comparison | 2 | SEC filing |
| Jan 25, 2022 | Initial | $1 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-520694
Source: Form D, filed Aug 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joyce Cacho | Director |
| Thibault Couturier | Director |
| Alexander Eaton | Director, Executive, Promoter |
| Liesbet Mijlemans | Director |
| Marcus Watson | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Calle Puebla 124, Colonia Roma Norte
Mexico City, O5, 06170
Mexico City, O5, 06170